Evaluating a patient's request for life-prolonging treatment: an ethical framework

por Winkler, Eva C, Hiddemann, Wolfgang, Marckmann, Georg
Publicado 2013

Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F

por Pastore, Friederike, Schneider, Stephanie, Christ, Oliver, Hiddemann, Wolfgang, Spiekermann, Karsten
Publicado 2013

The Role of Therapeutic Leukapheresis in Hyperleukocytotic AML

por Pastore, Friederike, Pastore, Alessandro, Wittmann, Georg, Hiddemann, Wolfgang, Spiekermann, Karsten
Publicado 2014

“Often Relatives are the Key […]” –Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life

por Laryionava, Katsiaryna, Hauke, Daniela, Heußner, Pia, Hiddemann, Wolfgang, Winkler, Eva C.
Publicado 2020

Care of cancer patients at the end of life in a German university hospital: A retrospective observational study from 2014

por Dasch, Burkhard, Kalies, Helen, Feddersen, Berend, Ruderer, Caecilie, Hiddemann, Wolfgang, Bausewein, Claudia
Publicado 2017

Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs

por Fiegl, Michael, Lindner, Lars H., Juergens, Matthias, Eibl, Hansjoerg, Hiddemann, Wolfgang, Braess, Jan
Publicado 2007

Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia – a single center analysis

por Sandner, Anne-Sophie, Weggel, Ramona, Mehraein, Yasmin, Schneider, Stephanie, Hiddemann, Wolfgang, Spiekermann, Karsten
Publicado 2019

LIFETIME CLOSE TO THE END: EFFECTS ON PERCEIVED TIME AND AGING IN OLDER ADULTS WITH ADVANCED CANCER

por Wahl, Hans-Werner, Laryionava, Katsiaryna, Schönstein, Anton, Heussner, Pia, Hiddemann, Wolfgang, Winkler, Eva
Publicado 2022

Experience of Time and Subjective Age When Facing a Limited Lifetime: The Case of Older Adults with Advanced Cancer

por Laryionava, Katsiaryna, Schönstein, Anton, Heußner, Pia, Hiddemann, Wolfgang, Winkler, Eva C., Wahl, Hans-Werner
Publicado 2021

CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells

por Lichtenegger, Felix S., Mueller, Katharina, Otte, Bettina, Beck, Barbara, Hiddemann, Wolfgang, Schendel, Dolores J., Subklewe, Marion
Publicado 2012

The second patient? Family members of cancer patients and their role in end-of-life decision making

por Laryionava, Katsiaryna, Pfeil, Timo A., Dietrich, Mareike, Reiter-Theil, Stella, Hiddemann, Wolfgang, Winkler, Eva C.
Publicado 2018

Development and Evaluation of an Ethical Guideline for Decisions to Limit Life-Prolonging Treatment in Advanced Cancer: Protocol for a Monocentric Mixed-Method Interventional Study

por Laryionava, Katsiaryna, Mehlis, Katja, Bierwirth, Elena, Mumm, Friederike, Hiddemann, Wolfgang, Heußner, Pia, Winkler, Eva C
Publicado 2018

T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment

por Schnorfeil, Frauke M., Lichtenegger, Felix S., Emmerig, Katharina, Schlueter, Miriam, Neitz, Julia S., Draenert, Rika, Hiddemann, Wolfgang, Subklewe, Marion
Publicado 2015

Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report

por Milani, Valeria, Stangl, Stefan, Issels, Rolf, Gehrmann, Mathias, Wagner, Beate, Hube, Kathrin, Mayr, Doris, Hiddemann, Wolfgang, Molls, Michael, Multhoff, Gabriele
Publicado 2009

Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity

por Witter, Klaus, Reibke, Roland, Subklewe, Marion, Zahn, Robert, Kauke, Teresa, Spiekermann, Karsten, Spannagl, Michael, Tischer, Johanna, Hiddemann, Wolfgang, Dick, Andrea
Publicado 2014

A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia

por Niavarani, Ahmadreza, Herold, Tobias, Reyal, Yasmin, Sauerland, Maria C., Buchner, Thomas, Hiddemann, Wolfgang, Bohlander, Stefan K., Valk, Peter J. M., Bonnet, Dominique
Publicado 2016

Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia

por Vaikari, Vijaya Pooja, Du, Yang, Wu, Sharon, Zhang, Tian, Metzeler, Klaus, Batcha, Aarif M.N., Herold, Tobias, Hiddemann, Wolfgang, Akhtari, Mojtaba, Alachkar, Houda
Publicado 2020

Mammalian WDR12 is a novel member of the Pes1–Bop1 complex and is required for ribosome biogenesis and cell proliferation

por Hölzel, Michael, Rohrmoser, Michaela, Schlee, Martin, Grimm, Thomas, Harasim, Thomas, Malamoussi, Anastassia, Gruber-Eber, Anita, Kremmer, Elisabeth, Hiddemann, Wolfgang, Bornkamm, Georg W., Eick, Dirk
Publicado 2005

Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment f...

por Mir, Farheen, Mattiello, Federico, Grigg, Andrew, Herold, Michael, Hiddemann, Wolfgang, Marcus, Robert, Seymour, John F., Bolen, Christopher R., Knapp, Andrea, Nielsen, Tina, Casulo, Carla
Publicado 2020

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia

por Schnorfeil, Frauke, Lichtenegger, Felix, Geiger, Christiane, Köhnke, Thomas, Bücklein, Veit, Altmann, Torben, Wagner, Beate, Henschler, Reinhard, Bigalke, Iris, Kvalheim, Gunnar, Hiddemann, Wolfgang, Schendel, Dolores, Subklewe, Marion
Publicado 2014